CHEER HOLDING INC-A (CHR) Fundamental Analysis & Valuation

NASDAQ:CHR • KYG399731218

Current stock price

0.91 USD
+0.03 (+3.39%)
Last:

This CHR fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

6

1. CHR Profitability Analysis

1.1 Basic Checks

  • CHR had positive earnings in the past year.
  • CHR had a positive operating cash flow in the past year.
  • Each year in the past 5 years CHR has been profitable.
  • In the past 5 years CHR always reported a positive cash flow from operatings.
CHR Yearly Net Income VS EBIT VS OCF VS FCFCHR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 10M 20M 30M 40M

1.2 Ratios

  • The Return On Assets of CHR (6.82%) is better than 78.26% of its industry peers.
  • CHR has a better Return On Equity (7.68%) than 76.81% of its industry peers.
  • CHR's Return On Invested Capital of 6.27% is fine compared to the rest of the industry. CHR outperforms 76.81% of its industry peers.
  • The Average Return On Invested Capital over the past 3 years for CHR is below the industry average of 11.10%.
Industry RankSector Rank
ROA 6.82%
ROE 7.68%
ROIC 6.27%
ROA(3y)9.95%
ROA(5y)13.67%
ROE(3y)11.67%
ROE(5y)17.03%
ROIC(3y)9%
ROIC(5y)13.46%
CHR Yearly ROA, ROE, ROICCHR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 0 5 10 15 20 25

1.3 Margins

  • CHR has a better Profit Margin (16.81%) than 81.16% of its industry peers.
  • In the last couple of years the Profit Margin of CHR has declined.
  • CHR has a Operating Margin of 17.47%. This is amongst the best in the industry. CHR outperforms 82.61% of its industry peers.
  • In the last couple of years the Operating Margin of CHR has declined.
  • The Gross Margin of CHR (71.95%) is better than 65.22% of its industry peers.
  • CHR's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 17.47%
PM (TTM) 16.81%
GM 71.95%
OM growth 3Y-9.83%
OM growth 5YN/A
PM growth 3Y-8.55%
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5YN/A
CHR Yearly Profit, Operating, Gross MarginsCHR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 20 40 60

7

2. CHR Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CHR is creating value.
  • The number of shares outstanding for CHR has been increased compared to 1 year ago.
  • The number of shares outstanding for CHR has been increased compared to 5 years ago.
  • CHR has a worse debt/assets ratio than last year.
CHR Yearly Shares OutstandingCHR Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200K 400K 600K
CHR Yearly Total Debt VS Total AssetsCHR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

2.2 Solvency

  • CHR has an Altman-Z score of 2.49. This is not the best score and indicates that CHR is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.49, CHR is in the better half of the industry, outperforming 68.12% of the companies in the same industry.
  • CHR has a debt to FCF ratio of 1.05. This is a very positive value and a sign of high solvency as it would only need 1.05 years to pay back of all of its debts.
  • CHR has a Debt to FCF ratio of 1.05. This is in the better half of the industry: CHR outperforms 79.71% of its industry peers.
  • CHR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
  • CHR's Debt to Equity ratio of 0.00 is fine compared to the rest of the industry. CHR outperforms 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 1.05
Altman-Z 2.49
ROIC/WACC1.37
WACC4.57%
CHR Yearly LT Debt VS Equity VS FCFCHR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M

2.3 Liquidity

  • CHR has a Current Ratio of 8.29. This indicates that CHR is financially healthy and has no problem in meeting its short term obligations.
  • CHR has a better Current ratio (8.29) than 94.20% of its industry peers.
  • CHR has a Quick Ratio of 8.29. This indicates that CHR is financially healthy and has no problem in meeting its short term obligations.
  • The Quick ratio of CHR (8.29) is better than 94.20% of its industry peers.
Industry RankSector Rank
Current Ratio 8.29
Quick Ratio 8.29
CHR Yearly Current Assets VS Current LiabilitesCHR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M

1

3. CHR Growth Analysis

3.1 Past

  • CHR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -33.58%.
  • The Earnings Per Share has been growing by 18.98% on average over the past years. This is quite good.
  • CHR shows a decrease in Revenue. In the last year, the revenue decreased by -5.65%.
  • Measured over the past years, CHR shows a decrease in Revenue. The Revenue has been decreasing by -1.28% on average per year.
EPS 1Y (TTM)-33.58%
EPS 3Y-22.48%
EPS 5Y18.98%
EPS Q2Q%-15.99%
Revenue 1Y (TTM)-5.65%
Revenue growth 3Y-1.28%
Revenue growth 5YN/A
Sales Q2Q%-0.09%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CHR Yearly Revenue VS EstimatesCHR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 2024 50M 100M 150M

5

4. CHR Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 0.01, which indicates a rather cheap valuation of CHR.
  • CHR's Price/Earnings ratio is rather cheap when compared to the industry. CHR is cheaper than 100.00% of the companies in the same industry.
  • Compared to an average S&P500 Price/Earnings ratio of 25.23, CHR is valued rather cheaply.
Industry RankSector Rank
PE 0.01
Fwd PE N/A
CHR Price Earnings VS Forward Price EarningsCHR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Based on the Price/Free Cash Flow ratio, CHR is valued cheaper than 100.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF 0.49
EV/EBITDA -6.44
CHR Per share dataCHR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60 80 100

4.3 Compensation for Growth

  • The decent profitability rating of CHR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)0
EPS Next 2YN/A
EPS Next 3YN/A

0

5. CHR Dividend Analysis

5.1 Amount

  • CHR does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

CHR Fundamentals: All Metrics, Ratios and Statistics

CHEER HOLDING INC-A

NASDAQ:CHR (3/23/2026, 4:04:06 PM)

0.91

+0.03 (+3.39%)

Chartmill FA Rating
GICS IndustryGroupMedia & Entertainment
GICS IndustryInteractive Media & Services
Earnings (Last)03-09
Earnings (Next)07-28
Inst Owners7.78%
Inst Owner ChangeN/A
Ins Owners11.98%
Ins Owner Change0%
Market Cap4.27M
Revenue(TTM)147.13M
Net Income(TTM)24.73M
Analysts80
Price TargetN/A
Short Float %4.15%
Short Ratio1.41
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 0.01
Fwd PE N/A
P/S 0.03
P/FCF 0.49
P/OCF 0.13
P/B 0.01
P/tB 0.02
EV/EBITDA -6.44
EPS(TTM)115.79
EY12724.18%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)1.85
FCFY203.24%
OCF(TTM)7.15
OCFY785.77%
SpS31.37
BVpS68.68
TBVpS60.41
PEG (NY)N/A
PEG (5Y)0
Graham Number423
Profitability
Industry RankSector Rank
ROA 6.82%
ROE 7.68%
ROCE 7.94%
ROIC 6.27%
ROICexc 16.86%
ROICexgc 24.86%
OM 17.47%
PM (TTM) 16.81%
GM 71.95%
FCFM 5.9%
ROA(3y)9.95%
ROA(5y)13.67%
ROE(3y)11.67%
ROE(5y)17.03%
ROIC(3y)9%
ROIC(5y)13.46%
ROICexc(3y)21.89%
ROICexc(5y)25.49%
ROICexgc(3y)29.91%
ROICexgc(5y)33.2%
ROCE(3y)11.4%
ROCE(5y)17.04%
ROICexgc growth 3Y-11.82%
ROICexgc growth 5YN/A
ROICexc growth 3Y-18.62%
ROICexc growth 5YN/A
OM growth 3Y-9.83%
OM growth 5YN/A
PM growth 3Y-8.55%
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5YN/A
F-Score5
Asset Turnover0.41
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 1.05
Debt/EBITDA 0.05
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 68.37
Cash Conversion 113.73%
Profit Quality 35.07%
Current Ratio 8.29
Quick Ratio 8.29
Altman-Z 2.49
F-Score5
WACC4.57%
ROIC/WACC1.37
Cap/Depr(3y)311.55%
Cap/Depr(5y)232.74%
Cap/Sales(3y)7.33%
Cap/Sales(5y)5.21%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-33.58%
EPS 3Y-22.48%
EPS 5Y18.98%
EPS Q2Q%-15.99%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-5.65%
Revenue growth 3Y-1.28%
Revenue growth 5YN/A
Sales Q2Q%-0.09%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-21.24%
EBIT growth 3Y-10.99%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-84.93%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-48.84%
OCF growth 3Y-21.03%
OCF growth 5YN/A

CHEER HOLDING INC-A / CHR Fundamental Analysis FAQ

What is the fundamental rating for CHR stock?

ChartMill assigns a fundamental rating of 5 / 10 to CHR.


Can you provide the valuation status for CHEER HOLDING INC-A?

ChartMill assigns a valuation rating of 5 / 10 to CHEER HOLDING INC-A (CHR). This can be considered as Fairly Valued.


Can you provide the profitability details for CHEER HOLDING INC-A?

CHEER HOLDING INC-A (CHR) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for CHR stock?

The Price/Earnings (PE) ratio for CHEER HOLDING INC-A (CHR) is 0.01 and the Price/Book (PB) ratio is 0.01.


How financially healthy is CHEER HOLDING INC-A?

The financial health rating of CHEER HOLDING INC-A (CHR) is 7 / 10.